Schedule 13D ownership disclosure

OncBioMune Pharmaceuticals, Inc

Security class unavailable · CUSIP: 68235A101

Event date: 2015-09-02

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
16,926,079
Percent of class
31.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-16-007175
Form type
SC 13D
Filer
ELLIOT ROBERT LANGE JR
CIK
CIK 1653954
Filed
Feb 04, 2016
Reporting period
Sep 02, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub